ACOR Annual Total Liabilities
$266.48 M
-$35.49 M-11.75%
31 December 2023
Summary:
As of February 2, 2025, ACOR annual total liabilities is $266.48 million, with the most recent change of -$35.49 million (-11.75%) on December 31, 2023. During the last 3 years, it has fallen by -$128.24 million (-32.49%).ACOR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Quarterly Total Liabilities
$267.35 M
+$865.00 K+0.32%
31 March 2024
Summary:
As of February 2, 2025, ACOR quarterly total liabilities is $267.35 million, with the most recent change of +$865.00 thousand (+0.32%) on March 31, 2024. Over the past year, it has stayed the same.ACOR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.8% | 0.0% |
| 3 y3 years | -32.5% | 0.0% |
| 5 y5 years | -61.3% | 0.0% |
ACOR Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -61.2% | -62.5% |
Acorda Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $267.35 M(+0.3%) |
| Dec 2023 | $266.48 M(-11.8%) | $266.48 M(-13.3%) |
| Sept 2023 | - | $307.39 M(+3.6%) |
| June 2023 | - | $296.83 M(-0.4%) |
| Mar 2023 | - | $297.95 M(-1.3%) |
| Dec 2022 | $301.97 M(-0.8%) | $301.97 M(-4.9%) |
| Sept 2022 | - | $317.57 M(-0.3%) |
| June 2022 | - | $318.40 M(+7.4%) |
| Mar 2022 | - | $296.59 M(-2.5%) |
| Dec 2021 | $304.33 M(-22.9%) | $304.33 M(+0.9%) |
| Sept 2021 | - | $301.61 M(+0.2%) |
| June 2021 | - | $301.02 M(-20.3%) |
| Mar 2021 | - | $377.77 M(-4.3%) |
| Dec 2020 | $394.73 M(-19.3%) | $394.73 M(-0.6%) |
| Sept 2020 | - | $396.92 M(-9.2%) |
| June 2020 | - | $437.30 M(-2.2%) |
| Mar 2020 | - | $447.15 M(-8.5%) |
| Dec 2019 | $488.90 M(-28.9%) | $488.90 M(-18.3%) |
| Sept 2019 | - | $598.57 M(-8.3%) |
| June 2019 | - | $652.63 M(-2.2%) |
| Mar 2019 | - | $667.35 M(-3.0%) |
| Dec 2018 | $687.68 M(+1.4%) | $687.68 M(-3.5%) |
| Sept 2018 | - | $712.46 M(+10.6%) |
| June 2018 | - | $643.98 M(+1.1%) |
| Mar 2018 | - | $637.15 M(-6.0%) |
| Dec 2017 | $677.98 M(-0.0%) | $677.98 M(+1.9%) |
| Sept 2017 | - | $665.07 M(+3.5%) |
| June 2017 | - | $642.72 M(-0.2%) |
| Mar 2017 | - | $643.72 M(-5.1%) |
| Dec 2016 | $678.12 M(+33.4%) | $678.12 M(+4.1%) |
| Sept 2016 | - | $651.60 M(-2.0%) |
| June 2016 | - | $665.00 M(+26.0%) |
| Mar 2016 | - | $527.68 M(+3.8%) |
| Dec 2015 | $508.27 M(-3.2%) | $508.27 M(-3.3%) |
| Sept 2015 | - | $525.39 M(-2.8%) |
| June 2015 | - | $540.27 M(-1.8%) |
| Mar 2015 | - | $549.96 M(+4.8%) |
| Dec 2014 | $524.81 M | $524.81 M(+16.7%) |
| Sept 2014 | - | $449.85 M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $442.94 M(+174.5%) |
| Mar 2014 | - | $161.37 M(-3.2%) |
| Dec 2013 | $166.77 M(-7.0%) | $166.77 M(+4.1%) |
| Sept 2013 | - | $160.26 M(-6.3%) |
| June 2013 | - | $171.11 M(-1.5%) |
| Mar 2013 | - | $173.78 M(-3.1%) |
| Dec 2012 | $179.41 M(+2.9%) | $179.41 M(+8.7%) |
| Sept 2012 | - | $164.99 M(-4.9%) |
| June 2012 | - | $173.40 M(+3.9%) |
| Mar 2012 | - | $166.96 M(-4.2%) |
| Dec 2011 | $174.28 M(-8.7%) | $174.28 M(+6.1%) |
| Sept 2011 | - | $164.18 M(-5.3%) |
| June 2011 | - | $173.34 M(-4.5%) |
| Mar 2011 | - | $181.42 M(-4.9%) |
| Dec 2010 | $190.84 M(+4.8%) | $190.84 M(+0.9%) |
| Sept 2010 | - | $189.06 M(+9.1%) |
| June 2010 | - | $173.29 M(-11.0%) |
| Mar 2010 | - | $194.77 M(+6.9%) |
| Dec 2009 | $182.14 M(+145.0%) | $182.14 M(+0.5%) |
| Sept 2009 | - | $181.32 M(-7.7%) |
| June 2009 | - | $196.37 M(+179.8%) |
| Mar 2009 | - | $70.17 M(-5.6%) |
| Dec 2008 | $74.34 M(+16.4%) | $74.34 M(+1.0%) |
| Sept 2008 | - | $73.63 M(+2.3%) |
| June 2008 | - | $71.99 M(+3.7%) |
| Mar 2008 | - | $69.43 M(+8.7%) |
| Dec 2007 | $63.87 M(-2.8%) | $63.87 M(+3.3%) |
| Sept 2007 | - | $61.84 M(-2.2%) |
| June 2007 | - | $63.23 M(+16.0%) |
| Mar 2007 | - | $54.50 M(-17.1%) |
| Dec 2006 | $65.70 M(-56.3%) | $65.70 M(+34.9%) |
| Sept 2006 | - | $48.71 M(+5.0%) |
| June 2006 | - | $46.39 M(-6.9%) |
| Mar 2006 | - | $49.84 M(-66.9%) |
| Dec 2005 | $150.45 M(+64.3%) | $150.45 M(+18.3%) |
| Sept 2005 | - | $127.21 M(+221.7%) |
| Dec 2004 | $91.55 M(+98.6%) | - |
| Dec 2003 | $46.09 M(+56.4%) | - |
| Sept 2003 | - | $39.54 M |
| June 2003 | $29.48 M | - |
FAQ
- What is Acorda Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Acorda Therapeutics?
- What is Acorda Therapeutics annual total liabilities year-on-year change?
- What is Acorda Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly total liabilities year-on-year change?
What is Acorda Therapeutics annual total liabilities?
The current annual total liabilities of ACOR is $266.48 M
What is the all time high annual total liabilities for Acorda Therapeutics?
Acorda Therapeutics all-time high annual total liabilities is $687.68 M
What is Acorda Therapeutics annual total liabilities year-on-year change?
Over the past year, ACOR annual total liabilities has changed by -$35.49 M (-11.75%)
What is Acorda Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ACOR is $267.35 M
What is the all time high quarterly total liabilities for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly total liabilities is $712.46 M
What is Acorda Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ACOR quarterly total liabilities has changed by $0.00 (0.00%)